| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
|
Lee, Keun Seok
|
|
2007
|
109 |
3 |
p. 481-489
|
artikel
|
| 2 |
BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy
|
Schlich-Bakker, Kathryn J.
|
|
2007
|
109 |
3 |
p. 507-514
|
artikel
|
| 3 |
Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75
|
Puig, Teresa
|
|
2007
|
109 |
3 |
p. 471-479
|
artikel
|
| 4 |
Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques
|
Konecny, Michal
|
|
2007
|
109 |
3 |
p. 581-583
|
artikel
|
| 5 |
Indole-3-carbinol-induced modulation of NF-κB signalling is breast cancer cell-specific and does not correlate with cell death
|
Moiseeva, Elena P.
|
|
2007
|
109 |
3 |
p. 451-462
|
artikel
|
| 6 |
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings
|
Yang, Wei T.
|
|
2007
|
109 |
3 |
p. 417-426
|
artikel
|
| 7 |
NSAID use and breast cancer risk in the VITAL cohort
|
Ready, Ann
|
|
2007
|
109 |
3 |
p. 533-543
|
artikel
|
| 8 |
Parity and disparity in first course treatment of invasive breast cancer
|
Lund, Mary Jo
|
|
2007
|
109 |
3 |
p. 545-557
|
artikel
|
| 9 |
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up
|
Saverio, Salomone Di
|
|
2007
|
109 |
3 |
p. 405-416
|
artikel
|
| 10 |
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors
|
Kwan, Marilyn L.
|
|
2007
|
109 |
3 |
p. 573-579
|
artikel
|
| 11 |
Pre-administration of docetaxel protects against adriamycin-induced cardiotoxicity
|
Sakaguchi, Hiromi
|
|
2007
|
109 |
3 |
p. 443-450
|
artikel
|
| 12 |
Precancerous model of human breast epithelial cells induced by NNK for prevention
|
Siriwardhana, Nalin
|
|
2007
|
109 |
3 |
p. 427-441
|
artikel
|
| 13 |
Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer
|
Urruticoechea, Ander
|
|
2007
|
109 |
3 |
p. 463-470
|
artikel
|
| 14 |
Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen
|
Campone, Mario
|
|
2007
|
109 |
3 |
p. 491-501
|
artikel
|
| 15 |
Sentinel node biopsy in patients with multiple breast cancer
|
Kim, Hee Jeong
|
|
2007
|
109 |
3 |
p. 503-506
|
artikel
|
| 16 |
SSRI use and breast cancer risk by hormone receptor status
|
Coogan, Patricia F.
|
|
2007
|
109 |
3 |
p. 527-531
|
artikel
|
| 17 |
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women
|
Cella, David
|
|
2007
|
109 |
3 |
p. 515-526
|
artikel
|
| 18 |
30th Annual San Antonio Breast Cancer Symposium Late Breaking Abstracts
|
|
|
2008
|
109 |
3 |
p. 585-594
|
artikel
|
| 19 |
The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer
|
Nout, R. A.
|
|
2007
|
109 |
3 |
p. 567-572
|
artikel
|
| 20 |
The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data
|
Shiroiwa, Takeru
|
|
2007
|
109 |
3 |
p. 559-566
|
artikel
|
Tijdschrift beschrijving